Entry Detail



General Information

Database ID:exR0268244
RNA Name:hsa-miR-641
RNA Type:miRNA
Chromosome:chr19
Starnd:-
Coordinate:
Start Site(bp):40282603End Site(bp):40282626
External Links:hsa-miR-641



Disease Information

Disease Name:Cystic Fibrosis
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D003550
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fibrosis, Cystic//Mucoviscidosis//Pulmonary Cystic Fibrosis//Cystic Fibrosis, Pulmonary//Pancreatic Cystic Fibrosis//Cystic Fibrosis, Pancreatic//Fibrocystic Disease of Pancreas//Pancreas Fibrocystic Disease//Pancreas Fibrocystic Diseases//Cystic Fibrosis of Pancreas



Expression Detail

GEO ID:GSE135119
Description:Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis
Experimental Design:Disease vs Control
Case Disease Type:Cystic Fibrosis
Case Disease SubType:NA
Case Sample:Cystic Fibrosis
Control Sample:Healthy
Number of Case:5
Number of Control:5
Number of Samples:10





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AIF1L
chr9
131096476
131123152
+
AKT2
chr19
40230317
40285536
-
C19orf47
chr19
40319536
40348527
-
CDKN1A
chr6
36676460
36687339
+
F11R
chr1
160995211
161021343
-
FOXN3
chr14
89124871
89619149
-
GATAD2B
chr1
153789030
153923360
-
GCNT2
chr6
10492223
10629368
+
GNPTAB
chr12
101745499
101830959
-
HMGA2
chr12
65824131
65966295
+
ICE1
chr5
5420664
5490220
+
JPT1
chr17
75135248
75168281
-
LSM14A
chr19
34172504
34229515
+
MED13L
chr12
115953872
116277719
-
PRSS16
chr6
27247701
27256624
+
SETD7
chr4
139495941
139606699
-
SOCS3
chr17
78356778
78360077
-
SYNJ2BP
chr14
70366499
70417090
-
SYNJ2BP-COX16
chr14
70326064
70417074
-
ZDHHC6
chr10
112424428
112446917
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001085
chr2
191765289
191789319
+
hsa_circ_0001168
chr20
47691321
47707559
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC125257.1
chr17
41848518
41851447
-
AC239868.1
chr1
149861271
149862504
+
AL034397.3
chrX
66015461
66020422
+
AL049795.2
chr1
32170733
32176568
+
AL355075.4
chr14
20343048
20343685
-
DLEU2
chr13
49956670
50125720
-
LINC00641
chr14
21200079
21206900
-
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
OIP5-AS1
chr15
41283990
41309737
+
SNHG1
chr11
62851984
62855953
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE135119
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL19117
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2346
Sample treatment protocol:NA
RNA Extract protocol:Frozen samples; Mixture with Trizol Reagent followed by extraction with RNA Clean and Concentrator kit.
RNA library preparation protocol:Using the Affymetrix GeneChip miRNA 4.0 array, 8ul of plasma from each sample was labelled using FlashTag Biotin RNA Labelling kit.



Reference

PMID:31664087
Title:Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis
Author:Ideozu JE, Zhang X, Rangaraj V, McColley S, Levy H
Journal:Sci Rep. 2019 Oct 29;9(1):15483.
Description:we employed microarray technology to identify aberrantly expressed plasma ECmiRNAs in CF and elucidate the functional relevance of their targets.